Detalhe da pesquisa
1.
New perspectives in triple-negative breast cancer therapy based on treatments with TGFß1 siRNA and doxorubicin.
Mol Cell Biochem
; 475(1-2): 285-299, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888160